Veran's SPiN Drive Receives FDA Clearance | Veran Medical Technologies, Inc
LinkedIn Login

Connect healthcare products, companies and hospitals with your LinkedIn network.

Facebook Login

Interact with your Facebook network around healthcare products, companies and hospitals.

Login With Facebook
MedicExchange Login

Enjoy Premium Access as a MedicExchange Member.

       Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Facebook Twitter Linkedin
Facebook: MedicExchange
Twitter: MedicExchange
Healthcare Company News Veran Medical Technologies, Inc Veran's SPiN Drive Receives FDA Clearance

Veran's SPiN Drive Receives FDA Clearance

Company News - Veran Medical Technologies, Inc

Veran Medical Technologies Receives FDA Clearance to Market Electromagnetic Navigated Bronchoscopy Product: The SPiN Drive System

Veran Medical Technologies announced that it received clearance (K091934) from the U.S. Food and Drug Administration to market a product for the delivery of instruments through the pulmonary tract. "Veran is excited about this clearance as it allows the company to address a huge unmet clinical need in lung cancer diagnosis and treatment," said Jerome R. Edwards, Veran president and chief executive officer. "Leveraging our proprietary IG4 Platform Technology, currently on the market for percutaneous procedures, we are now able to launch our SPiN Drive System for endobronchial procedures."

Even without formal lung cancer screening, it is estimated that over 6 million Solitary Pulmonary Nodules (SPN's) are found each year in the US on chest CT scans. Lung Cancer is a deadly disease that fatally claims 85% of patients within five years. Many physicians believe the key to improved patient survival chances are linked to the definitive early diagnosis of lung cancer at Stage 1. However, SPN's in the peripheral lung are inaccessible with today's techniques and technologies, leaving patients on "watchful waiting" protocols of repeat CT scans for multiple years causing patient anxiety and significant costs added to the US Healthcare System.

Veran Medical Technologies SPiN Drive System acts as a GPS-like system to enable pulmonologists and surgeons to access these peripheral SPN's to immediately diagnose malignancy, stop the "watchful waiting" and reduce US Healthcare spending. Recently, the American Medical Association (AMA) issued a new Category 1 CPT code for the use of electromagnetic navigational bronchoscopy (ENB) devices to target to lesions or spots deep in the lungs. The company believes in the future that the SPiN Drive System may enable the delivery of several therapies to treat lung cancer at an early stage before it has spread to the lymphatic system when patients can be helped the most.

Source: Veran Medical Technologies

You can discuss about Veran Medical Technologies and its products & services in the Veran Medical Technologies Company User Group